Search keyWord :

SUS ENVIRONMENT Unveils New Opportunities with Opening Ceremony of Representative Office in Thailand

BANGKOK,Aug. 23,2024-- On August 22,2024,the opening ceremony of theSUS ENVIRONMENT Thailand Representative Office was held in Bangkok,Thailand. This marks the establishment of SUS ENVIRONMENT\'s fou

Aug 27, 2024 BLOCKCHAIN

TALENTA ACCELERATOR DEMO DAY

Driving Impact,Pioneering Solutions for a Better Tomorrow. JAKARTA,Indonesia,Aug. 27,2024-- August 26,2024,the TALENTA Accelerator Demo Day 2024 was presented by the United States Agency for Internati

Aug 27, 2024 MARKET

FORBES TRAVEL GUIDE TO ANNOUNCE LUXURY AIR TRAVEL AWARDS

Verified Air Travel Awards Will Debut October 22 ATLANTA,Aug. 27,2024--Forbes Travel Guide ("FTG")—the world\'s leading authority on luxury hospitality—will launch the inaugural Verified

Aug 27, 2024 REGULATION

Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials

Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI

Aug 27, 2024 CRYPTOCURRENCY

Major Joint Venture Awarded Consultancy Agreement of San Tin Technopole

Development bolsters housing supply,cultivates job opportunities and revitalizes community DALLAS,Aug. 27,2024-- Halcrow,a Jacobs-owned company and AECOM Joint Venture has secured a consultancy agree

Aug 27, 2024 REGULATION

Experts Agree On the Longevity of EMFACE's Non-Invasive Face-Lifting Effects

PRAGUE,Aug. 27,2024-- Continuous research by Dr.Yael Halaas (USA) and Dr. Woraphong Manuskiatti (Thailand) has unveiled the first evidence on the longer-term effectiveness of EMFACE,the innovative fac

Aug 27, 2024 CRYPTOCURRENCY

Telix Announces Reorganisation to Deliver on Strategic Priorities

MELBOURNE,Australia,Aug. 27,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces new leadership appointments as part of an internal reorganisation to align its operations

Aug 27, 2024 CYBERSECURITY

ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment

BEIJING,Aug. 27,2024--Shanghai Ark Biopharmaceutical Co.,Ltd. ("ArkBio"),a privately held,clinical-stage biopharmaceutical company today announced that Dr. Jim Wu,Chief Executive Officer of

Aug 27, 2024 BLOCKCHAIN

Iconic Australian Athletic Brand 2XU Partners with Pattern for International Repositioning

Pattern Supports 2XU to Transform Brand Perception,Boosting Average Selling Price by 25% MELBOURNE,Australia,Aug. 27,2024--Leading global ecommerce and marketplace accelerator,Pattern,today announced

Aug 27, 2024 CRYPTOCURRENCY

Tech experts and AI innovators to congregate at Tech Week Singapore 2024 this October

Senior executives from OpenAI,NVIDIA,Google,AI Singapore and IMDA will headline this year\'s main stage

Aug 27, 2024 MARKET